U.S. Markets closed

Top Ancillary Cannabis Plays

HENDERSON, NV / ACCESSWIRE / March 8, 2019 / There are three main kinds of marijuana stocks:

1. Marijuana producers who cultivate marijuana, produce cannabis products, and distribute the products to customers.

2. Ancillary products and services providers who supply the products and services needed for marijuana growers and others in the cannabis industry to conduct their business successfully.

3. Cannabis-focused drug makers which include biotech or pharmaceutical companies that specializes in developing prescription drugs based on ingredients from the cannabis plant.

Are you overlooking ancillary marijuana stocks? Although some ancillary marijuana stocks may not come into direct contact with the cannabis plant, they provide everything from funding and consulting services to packaging and equipment. More importantly, they tend to fly under the radar and may have more upside compared to the growers and drug makers.

One company ancillary cannabis company to research is CleanSpark, Inc. (CLSK). They have been ranked in the top 10 microgrids by Navigant Research. Their microgrid power solution for the cannabis industry cuts the monthly electricity bill of indoor grow-houses by up to 82%. That's a huge savings considering how much it generally costs producers.

Today we are highlighting: CleanSpark, Inc. (CLSK), Innovative Industrial Properties, Inc. (IIPR), Constellation Brands, Inc. (STZ), Aphria, Inc. (NYSE:APHA), Cronos Group Inc. (CRON) and Aurora Cannabis, Inc. (ACB).

CleanSpark, Inc. (CLSK) (Market Cap: $142.728M; Share Price: $3.44) has been doing a lot to impress investors. Besides the cannabis side, CLSK has an up to $18 million deal with NYSE company MAC, which has completed an acquisition adding $3.6 million in gross sales to CLSK's bottom line during early 2019 alone.

The company that counts itself as one of the very few OTC companies on the LD Micro Index (only 4% of the 1000 companies are OTC listed), has taken another step towards its growth trajectory by executing its contract outside of the United States (a tech. consultant on a large industrial park in Costa Rica).

_______

Ancillary Cannabis play, Innovative Industrial Properties, Inc. (IIPR) (Market Cap: $677.952M, Share Price: $69.35), recently announced that its operating partnership subsidiary, IIP Operating Partnership, LP, priced a private offering of $125 million aggregate principal amount of 3.75% exchangeable senior notes due 2024. The operating partnership has granted the initial purchasers of the Notes a 30-day option to purchase up to an additional $18.75 million aggregate principal amount of the Notes to cover over-allotments if any.

_______

Constellation Brands, Inc. (STZ) (Market Cap: $31.962B; Share Price: $167.64) entered the cannabis industry with a $4 Billion investment in producer Canopy Growth (CGC) to assist their entry into the cannabis-infused beverage market.

_______

Aphria, Inc. (APHA) (Market Cap: $2.459B; Share Price: $9.61) announced earlier this week that Health Canada has granted the company its license amendment, permitting Aphria to commence production in an additional 800,000 square feet of facilities at its Aphria One location, as part of the company's completed Part IV and Part V expansions.

_______

Cronos Group, Inc. (CRON) (Market Cap: $4.095B; Share Price: $22.31) will exit its investment in medical marijuana company Whistler Medical Marijuana and sell its 19% stake to Aurora Cannabis, Inc. (ACB) (Market Cap: $7.838B; Share Price: $7.58). ACB will pay about C$175 million for the stake with Cronos receiving about 2.5 million Aurora common shares worth an aggregate value of about C$24.6 million and another C$7.6 million upon reaching certain milestones.

Legal Disclaimer:

This article was written by Regal Consulting, LLC ("Regal Consulting"). Regal Consulting has agreed to a three-month term consulting agreement with CLSK dated 9/12/18. The agreement calls for $10,000 in cash, and 30,000 restricted 144 shares of CLSK per month. Regal and CLSK have signed an amendment to extend the contract for twelve months starting 10/10/18, and increased the cash component to $20,000 per month. CLSK has paid an additional $12,000 for services provided in November. CLSK has paid an additional $88,000 for services provided in December. CLSK has paid an additional $100,000 for services for January. CLSK has paid an additional $80,000 for services for February. Regal was paid an additional $30,000 for March services and possibly compensated more for March services in the future, at which time Regal will update this disclaimer. All payments were made directly by Clean Spark, Inc. to Regal Consulting, LLC. to provide investor relations services, of which this article is a part of. Regal Consulting also paid one thousand dollars cash to microcapspeculators.com to distribute this article. Regal Consulting may have a position in the securities mentioned in this article at the time of publication, and may increase or decrease its position without notice. This article is based on public information and the opinions of Regal Consulting. CLSK was given an opportunity to edit this article. This article contains forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any results predicted herein. Regal Consulting is not registered with any financial or securities regulatory authority, and does not provide or claim to provide investment advice.

http://www.regalconsultingllc.com/full legal disclaimer/

Full Legal Disclaimer Click Here.

Contact Information:

Company Name: ACR Communication LLC.

Contact Person: Media Manager

Email: info@microcapspeculators.com

Phone: 1-702-720-6310

Country: United States

SOURCE: ACR Communication LLC



View source version on accesswire.com:
https://www.accesswire.com/538467/Top-Ancillary-Cannabis-Plays